| Trial registration number
|
IRCT20140804018677N9 |
Full text link
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/56509
|
First author
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Afshin Zarghi
|
Contact
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
soodehrazeghi@gmail.com
|
Registration date
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-06-19
|
Recruitment status
Last imported at : July 29, 2021, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Positive test for COVID-19 according to WHO criteria and diagnosed with COVID-19 of mild to moderate severity
Willingness to participate in the project
age>18 years
|
Exclusion criteria
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Diagnosed with severe COVID-19 according to WHO criteria
Pregnancy
Using Omega-3 and/or vitamin E in 2 months before study initiation
Vitamin D deficiency
PN or EN need
Need for ICU admission
|
Number of arms
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Shahid Beheshti University of Medical Sciences
|
Inclusion age min
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mild/moderate disease at enrollment
|
Severity scale
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2: Mild/moderate disease at enrollment
|
Total sample size
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
40
|
primary outcome
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
respiratory rate
pulse rate
Interlukin-6
Tumor necrotising factor alpha
|
Notes
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : June 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 2231, "treatment_name": "Astaxanthin+omega 3 fatty acid+vitamin d+vitamin e", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|